Erector spinae plane block for minimally invasive lumbar spine surgery
Erector Spinae Plane Block in Patients Undergoing Minimally Invasive Lumbar Spine Surgery: A Randomized Controlled Trial
NA · Hospital for Special Surgery, New York · NCT05856539
This study tests if a special pain relief technique called the erector spinae plane block can help people recovering from a specific type of back surgery feel less pain and use fewer pain medications.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Hospital for Special Surgery, New York (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05856539 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of the erector spinae plane (ESP) block in patients undergoing minimally invasive transforaminal lumbar interbody fusion (TLIF). Participants will be randomly assigned to receive either the ESP block or standard care without it. The study aims to assess various outcomes, including opioid usage, postoperative pain levels, and recovery metrics. By comparing these two groups, the trial seeks to determine if the ESP block can reduce reliance on opioids and improve overall patient recovery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 scheduled for minimally invasive TLIF with an ASA classification of 1, 2, or 3.
Not a fit: Patients with ASA classification of 4 or higher, chronic opioid use, or those undergoing revision surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce opioid use and improve pain management for patients undergoing lumbar spine surgery.
How similar studies have performed: Other studies have shown promising results with the use of ESP blocks in similar surgical contexts, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-80 * Patients scheduled for MIS TLIF (any level) with the principal investigator * ASA 1, 2, 3 Exclusion Criteria: * ASA 4 or higher * BMI \>40 * Chronic opioid use (daily use for \> 3 months) * Revision surgery, any history of previous lumbar spine surgery * Allergy to any of the study medications * Non-English speaking * Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure) * Pregnancy * Any concomitant surgery
Where this trial is running
New York, New York
- Hospital for Special Surgery — New York, New York, United States (RECRUITING)
Study contacts
- Study coordinator: Sheeraz Qureshi, MD, MBA
- Email: gangh@hss.edu
- Phone: 919-260-9699
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Patients With Spinal Stenosis Indicated for MIS TLIF, Erector spinae plane block, Transforaminal lumbar interbody fusion, Minimally invasive spine surgery, Lumbar spine, Spinal fusion